PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology
International Journal of Molecular Sciences · 19.11.2026 · 27 (22) · 10417
DOI: 10.3390/ijms272210417 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2026. Verfasst von José María Sayagués und 7 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Gene fusions are clinically relevant oncogenic drivers and therapeutic targets across multiple solid tumors. RSPO3 rearrangements have been described primarily in colorectal carcinoma and traditional serrated adenoma of the colorectum and have only rarely been reported in cholangiocarcinoma. Here, we describe a patient with perihilar cholangiocarcinoma (pCCA), Bismuth–Corlette type IV, with imaging findings suspicious for advanced/metastatic disease, harboring a PTPRK::RSPO3 fusion, together with ERBB2 p.S310F and TP53 p.I195T mutations, identified by next-generation sequencing (NGS) performed on a brush cytology specimen obtained from the primary biliary stricture during endoscopic retrograde cholangiopancreatography (ERCP). Fluorescence in situ hybridization (FISH) confirmed an RSPO3 rearrangement consistent with the NGS-identified PTPRK::RSPO3 fusion. RSPO3 fusions are known to enhance ligand-dependent WNT/β-catenin signaling in other tumor contexts, although the functional consequences of this alteration were not directly assessed in the index tumor. Exploratory analysis of RSPO3-associated transcriptional programs in a public pCCA cohort identified associations between higher RSPO3 expression and distinct transcriptional programs, most notably epithelial–mesenchymal transition (EMT), as well as global and TCF-dependent WNT signaling. These findings provide broader biological context for the molecular alteration but do not establish fusion-driven pathway activation. Together, these findings provide a case with PTPRK::RSPO3 fusion in pCCA, expand the spectrum of RSPO3 rearrangements described in biliary tract malignancies, and highlight the need for further investigation into their biological and potential therapeutic relevance.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Sayagués, J. M., Hernández, M. A., Bueno-Sacristan, D., López, D. R., Corchete, L. A., Alonso-Márquez, M. T., Moyano-Sanz, E., & Montero, J. C. (2026). PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology. International Journal of Molecular Sciences, 27(22), 10417. https://doi.org/10.3390/ijms272210417
Vancouver
Sayagués JM, Hernández MA, Bueno-Sacristan D, López DR, Corchete LA, Alonso-Márquez MT, et al. PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology. International Journal of Molecular Sciences. 2026;27(22):10417. doi:10.3390/ijms272210417
BibTeX
@article{Sayagus2026,
author = {Sayagués, José María and Hernández, Mar Abad and Bueno-Sacristan, Diego and López, Diego Requena and Corchete, Luís Antonio and Alonso-Márquez, María Teresa and Moyano-Sanz, Estefania and Montero, Juan Carlos},
title = {PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10417},
doi = {10.3390/ijms272210417}
}
EUVIMED